These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11042508)

  • 21. [Acute myelomonocytic leukemia with mastocytosis in bone marrow].
    Natori H; Nakamura E; Tanaka K; Naito K; Egami K; Honda J; Osabe S; Imamura Y; Natori K; Yasuda K
    Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
    Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
    Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell leukemia.
    Georgin-Lavialle S; Lhermitte L; Dubreuil P; Chandesris MO; Hermine O; Damaj G
    Blood; 2013 Feb; 121(8):1285-95. PubMed ID: 23243287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
    Chantorn R; Shwayder T
    Pediatr Dermatol; 2012; 29(5):605-9. PubMed ID: 22329485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
    Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.
    Kaddu S; Zenahlik P; Beham-Schmid C; Kerl H; Cerroni L
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):966-78. PubMed ID: 10365929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.
    von Rüden T; Kandels S; Radaszkiewicz T; Ullrich A; Wagner EF
    Blood; 1992 Jun; 79(12):3145-58. PubMed ID: 1350740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells.
    Valent P; Samorapoompichit P; Sperr WR; Horny HP; Lechner K
    Hematol J; 2002; 3(2):90-4. PubMed ID: 12032870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
    Sundram UN; Natkunam Y
    J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of systemic mast cell disorders.
    Worobec AS
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):659-87, vii. PubMed ID: 10909045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serum tryptase test: an emerging robust biomarker in clinical hematology.
    Valent P; Sperr WR; Sotlar K; Reiter A; Akin C; Gotlib J; Horny HP; Arock M
    Expert Rev Hematol; 2014 Oct; 7(5):683-90. PubMed ID: 25169217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
    Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
    Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.